HM Payson & Co’s Voyager Therapeutics VYGR Stock Holding History

HM Payson & Co’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.75K	Hold	500	–	–	﹤0.01%	1064
2026 Q1	$1.93K	Sell	500 -500	-50%	-$1.97K	﹤0.01%	1048
2025 Q4	$3.93K	Sell	1,000 -500	-33%	-$2.21K	﹤0.01%	998
2025 Q3	$7K	Buy	1,500 +1,000	+200%	+$3.62K	﹤0.01%	926
2025 Q2	$1.55K	Sell	500 -500	-50%	-$1.61K	﹤0.01%	943
2025 Q1	$3.38K	Hold	1,000	–	–	﹤0.01%	933
2024 Q4	$5.67K	Hold	1,000	–	–	﹤0.01%	890
2024 Q3	$5.85K	Hold	1,000	–	–	﹤0.01%	891
2024 Q2	$7.91K	Hold	1,000	–	–	﹤0.01%	856
2024 Q1	$9.31K	Buy	1,000 +500	+100%	+$4.22K	﹤0.01%	825
2023 Q4	$4.22K	Hold	500	–	–	﹤0.01%	873
2023 Q3	$3.88K	Hold	500	–	–	﹤0.01%	892
2023 Q2	$5.72K	Hold	500	–	–	﹤0.01%	844
2023 Q1	$3.85K	Hold	500	–	–	﹤0.01%	874
2022 Q4	$3.05K	Hold	500	–	–	﹤0.01%	837
2022 Q3	$3K	Hold	500	–	–	﹤0.01%	896
2022 Q2	$3K	Hold	500	–	–	﹤0.01%	936
2022 Q1	$4K	Hold	500	–	–	﹤0.01%	936
2021 Q4	$1K	Sell	500 -2,000	-80%	-$6.82K	﹤0.01%	1062
2021 Q3	$7K	Hold	2,500	–	–	﹤0.01%	870
2021 Q2	$10K	Hold	2,500	–	–	﹤0.01%	822
2021 Q1	$12K	Buy	2,500 +200	+9%	+$1.36K	﹤0.01%	855
2020 Q4	$16K	Hold	2,300	–	–	﹤0.01%	814
2020 Q3	$25K	Hold	2,300	–	–	﹤0.01%	701
2020 Q2	$29K	Hold	2,300	–	–	﹤0.01%	610
2020 Q1	$21K	Hold	2,300	–	–	﹤0.01%	637
2019 Q4	$32K	Hold	2,300	–	–	﹤0.01%	653
2019 Q3	$40K	Hold	2,300	–	–	﹤0.01%	630
2019 Q2	$63K	Buy	+2,300	New	+$52.6K	﹤0.01%	562

Other funds holding VYGR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

HM Payson & Co's VYGR Position: Q2 2026 in Review

HM Payson & Co held its Voyager Therapeutics (VYGR) position steady in Q2 2026 at 500 shares worth $1.75K. The position accounts for ﹤0.01% of the portfolio, ranked #1064.

HM Payson & Co first reported a position in VYGR in Q2 2019 and has held it in 29 quarters since. The position peaked at $63K in Q2 2019. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

HM Payson & Co held 500 shares of Voyager Therapeutics worth $1.75K as of Q2 2026.
HM Payson & Co left its Voyager Therapeutics share count unchanged in Q2 2026.
Voyager Therapeutics made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #1064 holding.
HM Payson & Co first reported a position in Voyager Therapeutics in Q2 2019 and has held it in 29 quarters since.
HM Payson & Co's Voyager Therapeutics position peaked at $63K in Q2 2019.
136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.